Riobello C, Vivanco B, Reda S, López-Hernández A, García-Inclán C, Potes-Ares S, Cabal VN, López F, Llorente JL, Hermsen MA. Programmed death ligand-1 expression a  s immunotherapeutic target in sinonasal cancer. Head Neck 2018 [Epub ahead of print] Ver pdf

Rodrigo JP, Villaronga MÁ, Menéndez ST, Hermida-Prado F, Quer M, Vilaseca I, Allonca E, Pedregal Mallo D, Astudillo A, García-Pedrero JM. A novel role for Nanog as an early cancer Risk marker in patients with laryngeal precancerous lesions. Sci Rep. 2017;7:11110 Ver pdf

Costales Marcos M, López Álvarez F, Fernández-Vañes L, Gómez J, Llorente JL. Tratamiento con toxina botulínica del síndrome del primer mordisco Acta Otorrinolaringol Esp. 2017;68:284-8 Ver pdf

López-Hernández A, Pérez-Escuredo J, Vivanco B, García-Inclán C, Potes Ares S, Naves Cabal V, Riobello Suárez C, Costales M, López F, Llorente JL, Hermsen MA. Genomic profiling of intestinal-type sinonasal adenocarcinoma reveals subgroups of patients with distinct clinical outcomes. Head Neck 2018;40:259-73 Ver pdf

López F, Grau JJ,  Medina JA, Alobid I. Consenso español para el tratamiento de los tumores nasosinusales. Acta Otorrinolaringol Esp. 2017;68:226-234 Ver pdf

Grilli G, Suárez V, Muñoz MG, Costales M, Llorente JL. Tumores primarios del espacio parafaríngeo. Acta Otorrinolaringol Esp. 2017;68:138-144 Ver pdf

Núñez-Batalla F, Jáudenes-Casaubón C, Sequí-Canet JM, Vivanco-Allende A, Zubicaray-Ugarteche J, Cabanillas-Farpón R. Diagnóstico etiológico de la sordera infantil: recomendaciones de la CODEPEH. Acta Otorrinolaringol Esp. 2017;68:43-55.  Ver pdf

López F, Sampedro T, Llorente JL, Hermsen M, Álvarez-Marcos C. Alterations of p14 ARF, p15 INK4B and p16 INK4A genes in primary laryngeal squamous cell carcinoma. Pathol Oncol Res. 2017;23:63-71 Ver pdf

Costales M, López-Hernández A, García-Inclán C, Vivanco B, López F, Llorente JL, Hermsen M. Gene methylation profiling in sinonasal adenocarcinoma and squamous cell carcinoma. Otolaryngol Head Neck Surg. 2016;155:808-815 Ver pdf

García-Carracedo D, Villaronga MA, Álvarez-Teijeiro S, Hermida-Prado F, Santamaría I, Allonca E, Suárez-Fernández L, González MV, Balbín M, Astudillo A, Martínez-Camblor P, Su GH, Rodrigo JP, García-Pedrero JM. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas. Oncotarget. 2016;7:29780-93 Ver pdf

López F, Santamarta E, Martínez P, Sáiz-Ayala A, Llorente JL. Cavernous sinus throbosis during pregnancy. Auris Nasus Larynx 2017;44:232-236 Ver pdf

Pérez-Escuredo J, López-Hernández A, Costales M, López F, Potes Ares S, Vivanco B, Llorente JL, Hermsen MA. Recurrent DNA copy number alterations in intestinal-type sinonasal adenocarcinoma. Rhinology. 2016;54:278-86.  Ver pdf

Llanos S, García-Pedrero Juana M, Morgado-Palacín Lucía, Rodrigo Juan P, Serrano M.  Stabilization of p21 by mTORC1/4E-BP1 predicts clinical outcome of head and neck cancers. Nat Commun. 2016;7:10438 Ver pdf

Menéndez ST, Villaronga MA, Rodrigo JP, Álvarez-Teijeiro S, Urdinquio RG, Fraga MF, Suárez C, García Pedrero JM. HERG1A potassium channel is the predominant isoform in head and neck squamous cell carcinomas: evidence for regulation by epigenetic mechanisms. Sci Rep. 2016 Jan 20;6:19666 Ver pdf

Rodrigo JP, Menéndez ST, Hermida-Prado F, Álvarez-Teijeiro S,  Villaronga MA, Alonso-Durán L, Vallina A, Martínez-Camblor P, Astudillo A, Suárez C, García-Pedrero JM. Clinical significance of Anoctamin-1 gene at 11q13 in the development and progression of head and neck squamous cell carcinomas. Sci Rep. 2015;5:15698 Ver pdf

PARD3 inactivation in lung squamous cell carcinomas impairs STAT3 and promotes malignant invasion. Bonastre E, Verdura S, Zondervan I, Facchinetti F, Lantuejoul S, Chiara MD, Rodrigo JP, Carretero J, Condom E, Vidal A, Sidransky D, Villanueva A, Roz L, Brambilla E, Savola E, Sánchez-Céspedes M. Cancer Res. 2015;75:1287-1297 Ver pdf

Diagnóstico etiológico de la sordera infantil: recomendaciones CODEPEH 2015 Ver pdf

López F, Suárez V, Vivanco B, Suárez C, Llorente JL. Current management of sinonasal undifferentiated carcinoma. Rhinology. 2015;53:212-220 Ver pdf

Llorente JL, López F, Suárez C, Hermsen M. Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances. Nat Rev Clin Oncol 2014;11:460–472 Ver pdf

García-Inclán C, López-Hernández A, Alonso-Guervós M, Allonca E, Potes S, Melón S; López F, Llorente JL, Hermsen M. Establishment and genetic characterization of six unique tumor cell lines as preclinical models for sinonasal squamous cell carcinoma. Sci Rep. 20144:4925  Ver pdf

Piazzolla D, Palla AR, Pantoja C, Cañamero M, Pérez de Castro I, Ortega S, Gómez-López G, Dominguez O, Megías D, Roncador G, Luque-García JL, Fernández-Tresguerres B, Fernandez AF, Fraga MF, Rodríguez-Justo M, Manzanares M, Sánchez-Carbayo M, García-Pedrero JM, Rodrigo JP, Malumbres M, Serrano M. Lineage-restricted function of the pluripotency factor NANOG in stratified epithelia. Nat Commun. 2014;5:4226 Ver pdf

Llorente JL, López F, Camporro D, Fueyo Á, Rial JC, de León R, Suárez C. Outcomes following microvascular free tissue transfer in reconstructing skull base defects. J Neurol Surg B Skull Base. 2013;74:324-330 Ver pdf